|
RBAK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.800900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.95976999999292E-05 |
| Normal-vs-Stage2 |
1.091800E-01 |
| Normal-vs-Stage3 |
7.142300E-02 |
| Normal-vs-Stage4 |
1.579840E-01 |
| Stage1-vs-Stage2 |
7.590800E-01 |
| Stage1-vs-Stage3 |
4.110300E-02 |
| Stage1-vs-Stage4 |
1.844260E-02 |
| Stage2-vs-Stage3 |
4.961000E-01 |
| Stage2-vs-Stage4 |
3.977200E-01 |
| Stage3-vs-Stage4 |
7.583000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.781400E-04 |
| Normal-vs-AfricanAmerican |
2.756800E-01 |
| Normal-vs-Asian |
6.983300E-03 |
| Caucasian-vs-AfricanAmerican |
1.426430E-01 |
| Caucasian-vs-Asian |
3.470600E-01 |
| AfricanAmerican-vs-Asian |
1.050210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.239590E-03 |
| Normal-vs-Female |
6.588600E-04 |
| Male-vs-Female |
6.826200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.190200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.027700E-04 |
| Normal-vs-Age(61-80Yrs) |
4.884700E-03 |
| Normal-vs-Age(81-100Yrs) |
3.843600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.628800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.701200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.744100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.532640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.923750E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.718200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.229200E-04 |
| Normal-vs-Grade 2 |
9.75580000006637E-07 |
| Normal-vs-Grade 3 |
5.159600E-02 |
| Normal-vs-Grade 4 |
8.737200E-01 |
| Grade 1-vs-Grade 2 |
5.445400E-01 |
| Grade 1-vs-Grade 3 |
1.763640E-02 |
| Grade 1-vs-Grade 4 |
4.044200E-03 |
| Grade 2-vs-Grade 3 |
4.630700E-04 |
| Grade 2-vs-Grade 4 |
5.59089999999651E-05 |
| Grade 3-vs-Grade 4 |
1.387420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.93040000004719E-06 |
| Normal-vs-ccB subtype |
7.736100E-03 |
| ccA subtype-vs-ccB subtype |
6.822400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.559430E-03 |
| Normal-vs-N1 |
4.464400E-01 |
| N0-vs-N1 |
6.887200E-01 |
|
|
